Tenax Therapeutics Statistics
Total Valuation
TENX has a market cap or net worth of $102.53 million. The enterprise value is -$15.44 million.
| Market Cap | 102.53M |
| Enterprise Value | -15.44M |
Important Dates
The next estimated earnings date is Monday, November 16, 2026, after market close.
| Earnings Date | Nov 16, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TENX has 57.28 million shares outstanding. The number of shares has increased by 31.87% in one year.
| Current Share Class | 37.42M |
| Shares Outstanding | 57.28M |
| Shares Change (YoY) | +31.87% |
| Shares Change (QoQ) | +12.48% |
| Owned by Insiders (%) | 0.21% |
| Owned by Institutions (%) | 60.35% |
| Float | 29.86M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.82 |
| P/TBV Ratio | 0.90 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 15.07, with zero debt.
| Current Ratio | 15.07 |
| Quick Ratio | 14.61 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -59.80% and return on invested capital (ROIC) is -39.54%.
| Return on Equity (ROE) | -59.80% |
| Return on Assets (ROA) | -37.70% |
| Return on Invested Capital (ROIC) | -39.54% |
| Return on Capital Employed (ROCE) | -60.40% |
| Weighted Average Cost of Capital (WACC) | 9.30% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$4.05M |
| Employee Count | 16 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -75.24% in the last 52 weeks. The beta is 0.92, so TENX's price volatility has been similar to the market average.
| Beta (5Y) | 0.92 |
| 52-Week Price Change | -75.24% |
| 50-Day Moving Average | 1.84 |
| 200-Day Moving Average | 10.07 |
| Relative Strength Index (RSI) | 44.70 |
| Average Volume (20 Days) | 2,044,936 |
Short Selling Information
The latest short interest is 7.23 million, so 12.62% of the outstanding shares have been sold short.
| Short Interest | 7.23M |
| Short Previous Month | 7.18M |
| Short % of Shares Out | 12.62% |
| Short % of Float | 24.21% |
| Short Ratio (days to cover) | 2.73 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -68.61M |
| Pretax Income | -64.86M |
| Net Income | -64.86M |
| EBITDA | n/a |
| EBIT | -68.61M |
| Earnings Per Share (EPS) | -$1.47 |
Balance Sheet
The company has $117.98 million in cash and no debt, with a net cash position of $117.98 million or $2.06 per share.
| Cash & Cash Equivalents | 117.98M |
| Total Debt | n/a |
| Net Cash | 117.98M |
| Net Cash Per Share | $2.06 |
| Equity (Book Value) | 113.59M |
| Book Value Per Share | 2.19 |
| Working Capital | 113.59M |
Cash Flow
| Operating Cash Flow | -46.03M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | n/a |
| Free Cash Flow | -46.03M |
| FCF Per Share | -$0.80 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TENX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -31.87% |
| Shareholder Yield | -31.87% |
| Earnings Yield | -81.97% |
| FCF Yield | -44.89% |
Analyst Forecast
The average price target for TENX is $9.63, which is 437.71% higher than the current price. The consensus rating is "Buy".
| Price Target | $9.63 |
| Price Target Difference | 437.71% |
| Analyst Consensus | Buy |
| Analyst Count | 10 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on January 3, 2024. It was a reverse split with a ratio of 1:80.
| Last Split Date | Jan 3, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:80 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |